Bristol-Myers Squibb Company (BMY) Gross margin 2016–2020
Bristol-Myers Squibb Company (BMY) gross margin by fiscal year — reported gross profit divided by reported revenue.
72.3%FY2020 · since FY2016: 74.5% → 72.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | 72.3% | +3.2 pp |
| FY2019 | 69.1% | -2.2 pp |
| FY2018 | 71.3% | +0.7 pp |
| FY2017 | 70.7% | -3.9 pp |
| FY2016 | 74.5% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice